tradingkey.logo

BRIEF-Sonnet Biotherapeutics' Proprietary ADC Platform Available For Drug Discovery Partnerships

ReutersFeb 19, 2025 3:29 PM

- Sonnet Biotherapeutics Holdings Inc SONN.O:

  • SONNET BIOTHERAPEUTICS ANNOUNCES THAT ITS PROPRIETARY ANTIBODY DRUG CONJUGATE (ADC) PLATFORM IS AVAILABLE FOR DRUG DISCOVERY PARTNERSHIPS WITH POTENTIAL FOR PRODUCING MULTIPLE PIPELINE DRUG CANDIDATES

Source text: [InGNX6BFnLK]

Further company coverage: SONN.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI